Bridging the Gap: How Patient Advocacy is Shaping Access

Looking Ahead: Patients as Partners

Patient advocacy must evolve from a consultative role to a collaborative partnership. This means: Co-developing clinical trial protocols with patients involved from design to dissemination.

Sitting at policy tables as equal stakeholders Funding patient-led research, ensuring that research questions reflect community priorities.

Strengthening data infrastructure so that realworld patient outcomes inform access decisions continuously

To build a truly patient-centred system, we must see patients not as passive recipients of care butasexpertsinlivedexperience acritical form of expertisethatistoooftenundervalued.

AdvocacyIsAccess

Canada’s drug access system is evolving, but not fast enough Patient advocates are helping to bridge that gap not just by raising their voices but by contributing research, shaping policy, offering peersupport,andholding institutionsaccountable.

Access to medications isn’t just a logistical issue it’s a moral imperative. Every day a patient waits is a day lost to pain, uncertainty, or preventable decline. Advocacy pushes the system to act faster, to act more fairly, and to center what matters most: the person behind the prescription

Inacountry whereuniversality isahealthcareideal,advocacy ensuresthatnooneisleftbehind.